Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare endocrine malignancy, often with an unfavorable prognosis. Here we summarize the knowledge about diagnosis, epidemiology, pathophysiology, and therapy of ACC. Over recent years, multidisciplinary clinics have formed and the first international treatment trials have been conducted. This review focuses on evidence gained from recent basic science and clinical research and provides perspectives from the experience of a large multidisciplinary clinic dedicated to the care of patients with ACC.

[1]  Larissa V Furtado,et al.  Adrenocortical carcinoma is a lynch syndrome-associated cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  E. Lalli,et al.  Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  M. Papotti,et al.  Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates. , 2013, Human pathology.

[4]  G. Hammer,et al.  Resection of adrenocortical carcinoma is less complete and local recurrence occurs sooner and more often after laparoscopic adrenalectomy than after open adrenalectomy. , 2012, Surgery.

[5]  G. Arnaldi,et al.  Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment. , 2012, The Journal of clinical endocrinology and metabolism.

[6]  C. Sempoux,et al.  Unusual DNA mismatch repair-deficient tumors in Lynch syndrome: a report of new cases and review of the literature. , 2012, Human pathology.

[7]  R. Kuick,et al.  Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-catenin. , 2012, The American journal of pathology.

[8]  J. Bilezikian,et al.  Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). , 2012, The Journal of clinical endocrinology and metabolism.

[9]  A. Rosato,et al.  Combination of sorafenib and everolimus impacts therapeutically on adrenocortical tumor models. , 2012, Endocrine-related cancer.

[10]  Kory Jasperson,et al.  Identification of Individuals at Risk for Lynch Syndrome Using Targeted Evaluations and Genetic Testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer Joint Practice Guideline , 2012, Journal of Genetic Counseling.

[11]  A. Berruti,et al.  Management of adjuvant mitotane therapy following resection of adrenal cancer , 2012, Endocrine.

[12]  Anders Sundin,et al.  Imaging of Adrenal Masses with Emphasis on Adrenocortical Tumors , 2012, Theranostics.

[13]  Zhoujun Shen,et al.  Myxoid adrenal cortical tumor: report of four cases. , 2012, Chinese medical journal.

[14]  J. Bertherat,et al.  Wnt/β-catenin signalling in adrenal physiology and tumour development , 2012, Molecular and Cellular Endocrinology.

[15]  M. Almeida,et al.  Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults , 2012, Molecular and Cellular Endocrinology.

[16]  B. Figueiredo,et al.  Molecular epidemiology of adrenocortical tumors in southern Brazil , 2012, Molecular and Cellular Endocrinology.

[17]  D. Malkin,et al.  Towards an understanding of the role of p53 in adrenocortical carcinogenesis , 2012, Molecular and Cellular Endocrinology.

[18]  T. Giordano,et al.  Gene expression profiling in adrenocortical neoplasia , 2012, Molecular and Cellular Endocrinology.

[19]  M. Fassnacht,et al.  TP53 germline mutations in adult patients with adrenocortical carcinoma. , 2012, The Journal of clinical endocrinology and metabolism.

[20]  S. Lowe,et al.  The microcosmos of cancer , 2012, Nature.

[21]  A. Tabarin,et al.  Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des Tumeurs Endocrines database. , 2012, European journal of endocrinology.

[22]  S. Asa,et al.  Carney complex with adrenal cortical carcinoma. , 2012, The Journal of clinical endocrinology and metabolism.

[23]  C. Stratakis,et al.  A large family with Carney complex caused by the S147G PRKAR1A mutation shows a unique spectrum of disease including adrenocortical cancer. , 2012, The Journal of clinical endocrinology and metabolism.

[24]  Min-Shu Hsieh,et al.  Myxoid Adrenal Cortical Carcinoma Presenting as Primary Hyperaldosteronism , 2011, International journal of surgical pathology.

[25]  Jie Gao,et al.  Myxoid adrenocortical neoplasms: a study of the clinicopathologic features and EGFR gene status of ten Chinese cases. , 2011, American journal of clinical pathology.

[26]  M. Papotti,et al.  The Weiss Score and Beyond—Histopathology for Adrenocortical Carcinoma , 2011, Hormones & cancer.

[27]  Michael Biehl,et al.  Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors , 2011, The Journal of clinical endocrinology and metabolism.

[28]  L. Ramalho,et al.  Wnt/beta-catenin pathway deregulation in childhood adrenocortical tumors. , 2011, The Journal of clinical endocrinology and metabolism.

[29]  I. Bourdeau,et al.  Identification of genetic alterations of AXIN2 gene in adrenocortical tumors. , 2011, The Journal of clinical endocrinology and metabolism.

[30]  R. Reznek,et al.  Adrenocortical carcinoma: the range of appearances on CT and MRI. , 2011, AJR. American journal of roentgenology.

[31]  E. Papini,et al.  AME position statement on adrenal incidentaloma. , 2011, European journal of endocrinology.

[32]  T. Fojo,et al.  MicroRNA profiling of adrenocortical tumors reveals miR‐483 as a marker of malignancy , 2011, Cancer.

[33]  T. Giordano.  The argument for mitotic rate-based grading for the prognostication of adrenocortical carcinoma. , 2011, The American journal of surgical pathology.

[34]  M. Platten,et al.  Oncocytic adrenocortical neoplasms--a clinicopathologic study of 13 new cases emphasizing the importance of their recognition. , 2011, Human pathology.

[35]  J. Bertherat,et al.  Transcriptome analysis of adrenocortical cancers: from molecular classification to the identification of new treatments. , 2011, Endocrine-related cancer.

[36]  A. Latronico,et al.  Clinical and molecular aspects of a pediatric metachronous adrenocortical tumor. , 2011, Arquivos brasileiros de endocrinologia e metabologia.

[37]  L. González,et al.  Adrenocortical carcinoma, an unusual extracolonic tumor associated with Lynch II syndrome , 2011, Familial Cancer.

[38]  J. Bertherat,et al.  β-Catenin Activation Is Associated with Specific Clinical and Pathologic Characteristics and a Poor Outcome in Adrenocortical Carcinoma , 2010, Clinical Cancer Research.

[39]  C. Boland,et al.  Health Benefits and Cost-Effectiveness of Primary Genetic Screening for Lynch Syndrome in the General Population , 2010, Cancer Prevention Research.

[40]  E. Caoili,et al.  Computed tomography of adrenocortical carcinoma containing macroscopic fat , 2010, Cancer imaging : the official publication of the International Cancer Imaging Society.

[41]  James A Brink,et al.  Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. , 2010, Journal of the American College of Radiology : JACR.

[42]  T. Giordano.  Adrenocortical tumors: an integrated clinical, pathologic, and molecular approach at the University of Michigan. , 2010, Archives of pathology & laboratory medicine.

[43]  T. Giordano,et al.  Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade , 2010, Langenbeck's Archives of Surgery.

[44]  F. Beuschlein,et al.  High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors. , 2010, The Journal of clinical endocrinology and metabolism.

[45]  M. Papotti,et al.  Adrenocortical Tumors With Myxoid Features: A Distinct Morphologic and Phenotypical Variant Exhibiting Malignant Behavior , 2010, The American journal of surgical pathology.

[46]  M. Yamakawa,et al.  Oncocytic adrenocortical carcinoma. , 2010, Annals of diagnostic pathology.

[47]  E. Lalli,et al.  Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors. , 2010, Cancer research.

[48]  S. Kaneko,et al.  Cushing’s syndrome and big IGF-II associated hypoglycaemia in a patient with adrenocortical carcinoma , 2010, BMJ Case Reports.

[49]  K. Leong,et al.  Use of anti-VEGF adjuvant therapy in cancer: challenges and rationale. , 2010, Trends in molecular medicine.

[50]  R. Eeles,et al.  Childhood predictive genetic testing for Li–Fraumeni syndrome , 2010, Familial Cancer.

[51]  C. Ritter,et al.  Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma. , 2010, European journal of endocrinology.

[52]  M. Olivier,et al.  Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect , 2010, Human mutation.

[53]  A. Coli,et al.  Sarcomatoid carcinoma of the adrenal gland: A case report and review of literature. , 2010, Pathology, research and practice.

[54]  Anthony J Gill,et al.  miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer , 2009, Clinical Cancer Research.

[55]  K. Nakao,et al.  Biallelic APC inactivation was responsible for functional adrenocortical adenoma in familial adenomatous polyposis with novel germline mutation of the APC gene: report of a case. , 2009, Japanese journal of clinical oncology.

[56]  M. Papotti,et al.  Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification , 2009, Histopathology.

[57]  Bhramar Mukherjee,et al.  Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. , 2009, Gastroenterology.

[58]  D. Stoppa-Lyonnet,et al.  Professionals assess the acceptability of preimplantation genetic diagnosis and prenatal diagnosis for managing inherited predisposition to cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[59]  Elliot K Fishman,et al.  Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls. , 2009, Radiographics : a review publication of the Radiological Society of North America, Inc.

[60]  P. Igaz,et al.  Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis. , 2009, Endocrine-related cancer.

[61]  G. Viani,et al.  Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials. , 2009, International journal of radiation oncology, biology, physics.

[62]  N. Aaronson,et al.  Attitude towards pre-implantation genetic diagnosis for hereditary cancer , 2009, Familial Cancer.

[63]  G. Hammer,et al.  Management of adrenocortical carcinoma. , 2009, The Journal of the National Comprehensive Cancer Network.

[64]  E. Lavezzo,et al.  Investigation of BRAFand CTNNB1 activating mutations in adrenocortical tumors , 2009, Journal of endocrinological investigation.

[65]  M. Bienvenu,et al.  18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients. , 2009, The Journal of clinical endocrinology and metabolism.

[66]  D. Iliopoulos,et al.  MicroRNA signature of primary pigmented nodular adrenocortical disease: clinical correlations and regulation of Wnt signaling. , 2009, Cancer research.

[67]  Martin Fassnacht,et al.  Clinical management of adrenocortical carcinoma. , 2009, Best practice & research. Clinical endocrinology & metabolism.

[68]  Ming-Tsan Lin,et al.  Early detection of adrenocortical carcinoma in a child with Li–Fraumeni syndrome , 2009, Pediatric blood & cancer.

[69]  L. Dehner,et al.  Adrenal Cortical Neoplasms in Children: Why So Many Carcinomas and Yet So Many Survivors? , 2009, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[70]  S. Sommer,et al.  Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[71]  M. Speicher,et al.  Predictive diagnosis of the cancer prone Li–Fraumeni syndrome by accident: new challenges through whole genome array testing , 2009, Journal of Medical Genetics.

[72]  C. Stratakis.  New genes and/or molecular pathways associated with adrenal hyperplasias and related adrenocortical tumors , 2009, Molecular and Cellular Endocrinology.

[73]  C. Clericuzio,et al.  Diagnostic criteria and tumor screening for individuals with isolated hemihyperplasia , 2009, Genetics in Medicine.

[74]  Bertrand Dousset,et al.  Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[75]  Paul G. Gauger,et al.  Molecular Classification and Prognostication of Adrenocortical Tumors by Transcriptome Profiling , 2009, Clinical Cancer Research.

[76]  F. Beuschlein,et al.  Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma , 2009, Cancer.

[77]  E. Lee,et al.  Genetic counseling can influence the course of a suspected familial cancer syndrome patient: from a case of Li-Fraumeni like syndrome with a germline mutation in the TP53 gene. , 2008, The Korean journal of laboratory medicine.

[78]  O. Debeir,et al.  Matrix metalloproteinase‐9 interplays with the IGFBP2–IGFII complex to promote cell growth and motility in astrocytomas , 2008, Glia.

[79]  J. Bertherat,et al.  Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors. , 2008, The Journal of clinical endocrinology and metabolism.

[80]  J. Ro,et al.  Myxoid adrenal cortical neoplasms. , 2008, Annals of diagnostic pathology.

[81]  S. Khatua,et al.  IGFBP2 Is Overexpressed by Pediatric Malignant Astrocytomas and Induces the Repair Enzyme DNA-PK , 2008, Journal of child neurology.

[82]  C. Lotfi,et al.  Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors. , 2008, The Journal of clinical endocrinology and metabolism.

[83]  G. Hammer,et al.  Targeted disruption of β-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex , 2008, Development.

[84]  F. Beuschlein,et al.  [123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes. , 2008, The Journal of clinical endocrinology and metabolism.

[85]  J. Kievit,et al.  Extremely long survival in six patients despite recurrent and metastatic adrenal carcinoma. , 2008, European journal of endocrinology.

[86]  M. Greene,et al.  Concise handbook of familial cancer susceptibility syndromes - second edition. , 2008, Journal of the National Cancer Institute. Monographs.

[87]  C. Bonaïti‐pellié,et al.  Molecular basis of the Li–Fraumeni syndrome: an update from the French LFS families , 2008, Journal of Medical Genetics.

[88]  William W Mayo-Smith,et al.  The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. , 2008, AJR. American journal of roentgenology.

[89]  V. Montori,et al.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. , 2008, The Journal of clinical endocrinology and metabolism.

[90]  Jeffrey M Trent,et al.  Adrenocortical carcinoma survival rates correlated to genomic copy number variants , 2008, Molecular Cancer Therapeutics.

[91]  P. Møller,et al.  Guidelines for the clinical management of familial adenomatous polyposis (FAP) , 2008, Gut.

[92]  T. Abe,et al.  Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas. , 2008, Endocrine journal.

[93]  Wei-ping Liu,et al.  Comparison of Immunohistochemical Markers in the Differential Diagnosis of Adrenocortical Tumors: Immunohistochemical Analysis of Adrenocortical Tumors , 2007, Applied immunohistochemistry & molecular morphology : AIMM.

[94]  D. Mikhailidis,et al.  Pheochromocytoma: an update on genetics and management. , 2007, Endocrine-related cancer.

[95]  Jeffrey E. Lee,et al.  Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma. , 2007, Surgery.

[96]  G. Zambetti,et al.  The p53 mutation “gradient effect” and its clinical implications , 2007, Journal of cellular physiology.

[97]  I. Bourdeau,et al.  Frequent mutations of β‐catenin gene in sporadic secreting adrenocortical adenomas * , 2007, Clinical endocrinology.

[98]  G. Fuller,et al.  Insulin-like growth factor binding protein 2 promotes glioma development and progression , 2007, Proceedings of the National Academy of Sciences.

[99]  N. Sonino,et al.  The role of 21-hydroxylase in the pathogenesis of adrenal masses: Review of the literature and focus on our own experience , 2007, Journal of endocrinological investigation.

[100]  H. Morreau,et al.  Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis , 2007, Clinical genetics.

[101]  R. Baxter,et al.  Expression of insulin-like growth factor binding protein-2 by MCF-7 breast cancer cells is regulated through the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway. , 2007, Endocrinology.

[102]  K. Yano,et al.  Matrix metalloproteinase‐7 triggers the matricrine action of insulin‐like growth factor‐II via proteinase activity on insulin‐like growth factor binding protein 2 in the extracellular matrix , 2007, Cancer science.

[103]  C. Stratakis,et al.  Primary pigmented nodular adrenocortical disease reveals insulin-like growth factor binding protein-2 regulation by protein kinase A. , 2007, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[104]  D. Leroith,et al.  The role of the IGF system in cancer growth and metastasis: overview and recent insights. , 2007, Endocrine reviews.

[105]  M. Rothmund,et al.  Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening , 2007, Langenbeck's Archives of Surgery.

[106]  E. Lalli,et al.  Gene expression profiling of childhood adrenocortical tumors. , 2007, Cancer research.

[107]  Salma K. Marani,et al.  Psychological functioning in persons considering genetic counseling and testing for Li–Fraumeni syndrome , 2006, Psycho-oncology.

[108]  Y. Novitsky,et al.  Outcomes of adrenal cortical carcinoma in the United States. , 2006, Surgery.

[109]  J. Qi,et al.  Imaging of primary adrenal lymphoma: case report and literature review , 2006, Acta radiologica.

[110]  S. Diaz-Cano,et al.  DNA and kinetic heterogeneity during the clonal evolution of adrenocortical proliferative lesions. , 2006, Human pathology.

[111]  J. Holly,et al.  The Role of Insulin-Like Growth Factor Binding Proteins , 2006, Neuroendocrinology.

[112]  C. Eng,et al.  Comprehensive mutation scanning of NF1 in apparently sporadic cases of pheochromocytoma. , 2006, The Journal of clinical endocrinology and metabolism.

[113]  D. Amor,et al.  Tumour surveillance in Beckwith–Wiedemann syndrome and hemihyperplasia: A critical review of the evidence and suggested guidelines for local practice , 2006, Journal of paediatrics and child health.

[114]  P. Boffetta,et al.  Mortality rate of adrenocortical tumors in children under 15 years of age in Curitiba, Brazil , 2006, Pediatric blood & cancer.

[115]  J. Bertherat,et al.  Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. , 2006, The Journal of clinical endocrinology and metabolism.

[116]  J. Wallis,et al.  Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma. , 2006, The Journal of clinical endocrinology and metabolism.

[117]  M. Kalra,et al.  Adrenocortical carcinoma: contrast washout characteristics on CT. , 2006, AJR. American journal of roentgenology.

[118]  Martin Fassnacht,et al.  Adrenocortical Carcinoma: Clinical Update , 2006 .

[119]  Matthias M. Weber,et al.  Overexpression of the insulin-like growth factor I receptor in human pheochromocytomas. , 2006, Journal of molecular endocrinology.

[120]  Electron Kebebew,et al.  Extent of Disease at Presentation and Outcome for Adrenocortical Carcinoma: Have We Made Progress? , 2006, World Journal of Surgery.

[121]  E. Baudin,et al.  Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography. , 2006, The Journal of clinical endocrinology and metabolism.

[122]  Q. Duh,et al.  Risk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy? , 2006, Journal of the American College of Surgeons.

[123]  R. Scolyer,et al.  Myxoid variant of adrenocortical carcinoma: Report of a unique case , 2006, Pathology international.

[124]  C. Maser-Gluth,et al.  Adrenocortical carcinoma producing 11-deoxycorticosterone: A rare cause of mineralocorticoid hypertension , 2005, Journal of endocrinological investigation.

[125]  B. Kleinschmidt-DeMasters,et al.  Pediatric Adrenal Cortical Carcinoma: Brain Metastases and Relationship to NF-1, Case Reports and Review of the Literature , 2005, Journal of Neuro-Oncology.

[126]  T. Kishore,et al.  Myxoid adrenal cortical carcinoma--a rare variant of adrenocortical carcinoma. , 2005, Indian journal of medical sciences.

[127]  S. Kim,et al.  PTEN/MMAC1 enhances the growth inhibition by anticancer drugs with downregulation of IGF-II expression in gastric cancer cells , 2005, Experimental & Molecular Medicine.

[128]  J. Bertherat,et al.  Molecular genetics of adrenocortical tumours, from familial to sporadic diseases. , 2005, European journal of endocrinology.

[129]  C. Croce,et al.  miR-15 and miR-16 induce apoptosis by targeting BCL2. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[130]  T. Giordano,et al.  Management of patients with adrenal cancer: recommendations of an international consensus conference. , 2005, Endocrine-related cancer.

[131]  R. Ribeiro,et al.  Biology, clinical characteristics, and management of adrenocortical tumors in children , 2005, Pediatric blood & cancer.

[132]  J. Bertherat,et al.  Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. , 2005, Cancer research.

[133]  P. Lapunzina.  Risk of tumorigenesis in overgrowth syndromes: A comprehensive review , 2005, American journal of medical genetics. Part C, Seminars in medical genetics.

[134]  P. Boffetta,et al.  Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation , 2005, Journal of Medical Genetics.

[135]  W. Frankel,et al.  Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). , 2005, The New England journal of medicine.

[136]  R. Kerber,et al.  A cohort study of cancer risk in relation to family histories of cancer in the Utah population database , 2005, Cancer.

[137]  A. Fassina,et al.  Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's syndrome with an ominous clinical course. , 2005, Endocrine-related cancer.

[138]  F. Berger,et al.  Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic Acid microarrays identifies several candidate genes as markers of malignancy. , 2005, The Journal of clinical endocrinology and metabolism.

[139]  L. Strong,et al.  Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni Syndrome , 2004, Cell.

[140]  T. Jacks,et al.  Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni Syndrome , 2004, Cell.

[141]  C. Sutter,et al.  Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli , 2004, Genes, chromosomes & cancer.

[142]  V. Narra,et al.  Adrenal masses: mr imaging features with pathologic correlation. , 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.

[143]  E. Pinto,et al.  Founder effect for the highly prevalent R337H mutation of tumor suppressor p53 in Brazilian patients with adrenocortical tumors. , 2004, Arquivos brasileiros de endocrinologia e metabologia.

[144]  R. Broaddus,et al.  Unusual tumors associated with the hereditary nonpolyposis colorectal cancer syndrome , 2004, Modern Pathology.

[145]  Y. Suh,et al.  Oncocytic adrenocortical carcinomas: A pathological and immunohistochemical study of four cases in comparison with conventional adrenocortical carcinomas , 2004, Pathology international.

[146]  M. Bisceglia,et al.  Adrenocortical Oncocytic Tumors: Report of 10 Cases and Review of the Literature , 2004, International journal of surgical pathology.

[147]  S. Hankinson,et al.  Insulin-like growth factors and neoplasia , 2004, Nature Reviews Cancer.

[148]  M. Haider,et al.  Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role? , 2004, Radiology.

[149]  C. Scott,et al.  The role of the M6P/IGF-II receptor in cancer: tumor suppression or garbage disposal? , 2004, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[150]  F. Collins,et al.  Molecular Pathology of the MEN1 Gene , 2004, Annals of the New York Academy of Sciences.

[151]  E. Balk,et al.  The clinically inapparent adrenal mass: update in diagnosis and management. , 2004, Endocrine reviews.

[152]  C. Rodríguez-Galindo,et al.  Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[153]  M. Goto,et al.  Unusual Double Primary Neoplasia: Adrenocortical and Ureteral Carcinomas in Werner Syndrome , 2004, Urologia Internationalis.

[154]  R. Jensen,et al.  Multiple Endocrine Neoplasia Type 1 and Zollinger-Ellison Syndrome: A Prospective Study of 107 Cases and Comparison With 1009 Cases From the Literature , 2004, Medicine.

[155]  J. Fata,et al.  Insulin-like Growth Factor-II Regulates PTEN Expression in the Mammary Gland* , 2003, Journal of Biological Chemistry.

[156]  M. Jordá,et al.  Melan A (A103) Is Expressed in Adrenocortical Neoplasms but Not in Renal Cell and Hepatocellular Carcinomas , 2003, Applied immunohistochemistry & molecular morphology : AIMM.

[157]  Robert A. Weinberg,et al.  Comparative Biology of Mouse versus Human Cells: Modelling Human Cancer in Mice O P I N I O N , 2022 .

[158]  A. Hoeflich,et al.  Increased Activity of Catalase in Tumor Cells Overexpressing IGFBP-2 , 2003, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[159]  R. Eeles,et al.  Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. , 2003, Cancer research.

[160]  L. Thompson,et al.  Adrenal Cortical Neoplasms in the Pediatric Population: A Clinicopathologic and Immunophenotypic Analysis of 83 Patients , 2003, The American journal of surgical pathology.

[161]  Y. I. Lee,et al.  PTEN modulates insulin‐like growth factor II (IGF‐II)‐mediated signaling; the protein phosphatase activity of PTEN downregulates IGF‐II expression in hepatoma cells , 2003, FEBS letters.

[162]  M. Bergström,et al.  11C-metomidate PET imaging of adrenocortical cancer , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[163]  Paul G Gauger,et al.  Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. , 2003, The American journal of pathology.

[164]  P. Devos,et al.  Weiss System Revisited: A Clinicopathologic and Immunohistochemical Study of 49 Adrenocortical Tumors , 2002, The American journal of surgical pathology.

[165]  M. Hoang,et al.  Oncocytic Adrenocortical Carcinoma: A Morphologic, Immunohistochemical and Ultrastructural Study of Four Cases , 2002, Modern Pathology.

[166]  E. Gabrielson,et al.  Variable levels of chromosomal instability and mitotic spindle checkpoint defects in breast cancer. , 2002, The American journal of pathology.

[167]  C. Nies,et al.  Adrenal Involvement in Multiple Endocrine Neoplasia Type 1 , 2002, World Journal of Surgery.

[168]  M. Jordá,et al.  Calretinin and Inhibin Are Useful in Separating Adrenocortical Neoplasms From Pheochromocytomas , 2002, Applied immunohistochemistry & molecular morphology : AIMM.

[169]  J. Wallace,et al.  Characteristics of binding of insulin-like growth factor (IGF)-I and IGF-II analogues to the type 1 IGF receptor determined by BIAcore analysis. , 2002, European journal of biochemistry.

[170]  F. Berger,et al.  TRANSCRIPTION PROFILING OF BENIGN AND MALIGNANT ADRENAL TUMORS BY cDNA MACRO-ARRAY ANALYSIS , 2002, Endocrine research.

[171]  A. Hoeflich,et al.  Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter? , 2001, Cancer research.

[172]  B. Ponder,et al.  Guidelines for diagnosis and therapy of MEN type 1 and type 2. , 2001, The Journal of clinical endocrinology and metabolism.

[173]  W. Zoller,et al.  [Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer]. , 2001, Zeitschrift fur Gastroenterologie.

[174]  E. Pinto,et al.  An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors. , 2001, The Journal of clinical endocrinology and metabolism.

[175]  E. Baudin,et al.  Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. , 2001, Cancer research.

[176]  G. Palù,et al.  Molecular analysis of CDKN1C and TP53 in sporadic adrenal tumors. , 2001, European journal of endocrinology.

[177]  T. Giordano,et al.  Overexpression of CXC chemokines by an adrenocortical carcinoma: a novel clinical syndrome. , 2001, The Journal of clinical endocrinology and metabolism.

[178]  Y. Chapuis,et al.  Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group , 2001, World Journal of Surgery.

[179]  M. Vazquez,et al.  Analysis of the methylation status of the KCNQ1OT and H19 genes in leukocyte DNA for the diagnosis and prognosis of Beckwith–Wiedemann syndrome , 2001, European Journal of Human Genetics.

[180]  J. Varley,et al.  Characterization of germline TP53 splicing mutations and their genetic and functional analysis , 2001, Oncogene.

[181]  W. Simonds,et al.  Multiple endocrine neoplasia type 1: new clinical and basic findings , 2001, Trends in Endocrinology & Metabolism.

[182]  K. Hemminki,et al.  Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families , 2001, International journal of cancer.

[183]  K. Kuzdak,et al.  Usefulness of VEGF, MMP-2, MMP-3 and TIMP-2 serum level evaluation in patients with adrenal tumours. , 2001, Endocrine regulations.

[184]  E. Nabeyrat,et al.  Distinct patterns of insulin-like growth factor binding protein (IGFBP)-2 and IGFBP-3 expression in oxidant exposed lung epithelial cells. , 2001, Biochimica et biophysica acta.

[185]  F. Collins,et al.  A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[186]  C. Bonaïti‐pellié,et al.  Sensitivity and predictive value of criteria for p53germline mutation screening , 2001, Journal of medical genetics.

[187]  A. Cats,et al.  Adrenocortical adenocarcinoma in an MSH2 carrier: coincidence or causal relation? , 2000, Human pathology.

[188]  R. Reznek,et al.  Adrenal masses are associated with familial adenomatous polyposis , 2000, Diseases of the colon and rectum.

[189]  E. Wolf,et al.  The role of the insulin‐like growth factor system in adrenocortical tumourigenesis , 2000, European journal of clinical investigation.

[190]  X. Bertagna,et al.  Expression of the angiogenesis markers vascular endothelial growth factor-A, thrombospondin-1, and platelet-derived endothelial cell growth factor in human sporadic adrenocortical tumors: correlation with genotypic alterations. , 2000, The Journal of clinical endocrinology and metabolism.

[191]  F. Kittrell,et al.  Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome. , 2000, The American journal of pathology.

[192]  I. Francis,et al.  Delayed enhanced CT of lipid-poor adrenal adenomas. , 2000, AJR. American journal of roentgenology.

[193]  D. Schwartz,et al.  Primary aldosteronism in a patient with familial adenomatous polyposis. , 2000, Mayo Clinic proceedings.

[194]  P. Lichter,et al.  Adrenocortical carcinoma is characterized by a high frequency of chromosomal gains and high‐level amplifications , 2000, Genes, chromosomes & cancer.

[195]  C. Bonaïti‐pellié,et al.  P53 germline mutations in childhood cancers and cancer risk for carrier individuals , 2000, British Journal of Cancer.

[196]  P. Heikkilä,et al.  Expression of inhibin alpha in adrenocortical tumours reflects the hormonal status of the neoplasm. , 2000, The Journal of endocrinology.

[197]  M. Kapoor,et al.  High metastatic potential in mice inheriting a targeted p53 missense mutation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[198]  H. Sasano,et al.  A case of renin-producing adrenocortical cancer. , 2000, Endocrine journal.

[199]  R. Lloyd,et al.  Myxoid neoplasms of the adrenal cortex: a rare histologic variant. , 2000, The American journal of surgical pathology.

[200]  A. Hoeflich,et al.  Overexpression of insulin-like growth factor-binding protein-2 results in increased tumorigenic potential in Y-1 adrenocortical tumor cells. , 2000, Cancer research.

[201]  G. Arnaldi,et al.  A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. , 2000, The Journal of clinical endocrinology and metabolism.

[202]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[203]  F. Beuschlein,et al.  Cortisol Producing Adrenal Adenoma—a New Manifestation of Gardner's Syndrome , 2000, Endocrine research.

[204]  K. Salmenkivi,et al.  P53 and Ki67 in Adrenocortical Tumors , 2000, Endocrine research.

[205]  K. Isselbacher,et al.  Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. , 1999, Science.

[206]  K. Köhrer,et al.  MEN I gene mutations in sporadic adrenal adenomas , 1999, Human Genetics.

[207]  D. O'Gorman,et al.  Decreased insulin-like growth factor-II/mannose 6-phosphate receptor expression enhances tumorigenicity in JEG-3 cells. , 1999, Cancer research.

[208]  E. Speel,et al.  Analysis of genomic alterations in sporadic adrenocortical lesions. Gain of chromosome 17 is an early event in adrenocortical tumorigenesis. , 1999, The American journal of pathology.

[209]  D. Evans,et al.  Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors. , 1999, American journal of human genetics.

[210]  A. Vortmeyer,et al.  Multiple endocrine neoplasia type 1: atypical presentation, clinical course, and genetic analysis of multiple tumors. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[211]  G. Altavilla,et al.  Inactivation of the p16 tumor suppressor gene in adrenocortical tumors. , 1999, The Journal of clinical endocrinology and metabolism.

[212]  Suna Wang,et al.  Expression of the wild-type insulin-like growth factor II receptor gene suppresses growth and causes death in colorectal carcinoma cells , 1999, Oncogene.

[213]  V. Budach,et al.  [Adrenal cortical carcinoma]. , 1999, Zhonghua wai ke za zhi [Chinese journal of surgery].

[214]  G. Nussdorfer,et al.  Adrenocortical oncocytoma: case report and review of the literature. , 1999, Tumori.

[215]  K. Nagao,et al.  11-Deoxycorticosterone-Producing Adrenocortical Carcinoma , 1999, Urologia Internationalis.

[216]  C. Larsson,et al.  Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16. , 1999, The Journal of clinical endocrinology and metabolism.

[217]  J. Beckwith,et al.  Vignettes from the history of overgrowth and related syndromes. , 1998, American journal of medical genetics.

[218]  H. Hoyme,et al.  Isolated hemihyperplasia (hemihypertrophy): report of a prospective multicenter study of the incidence of neoplasia and review. , 1998, American journal of medical genetics.

[219]  D. Pinkel,et al.  Retention of wild‐type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation , 1998, The EMBO journal.

[220]  P. Chène.  In vitro analysis of the dominant negative effect of p53 mutants. , 1998, Journal of molecular biology.

[221]  L. Medeiros,et al.  Oncocytic adrenocortical neoplasms: a report of seven cases and review of the literature. , 1998, American Journal of Surgical Pathology.

[222]  A. Horii,et al.  Adrenocortical tumor in a patient with familial adenomatous polyposis: a case associated with a complete inactivating mutation of the APC gene and unusual histological features. , 1998, Human pathology.

[223]  M. Ellis,et al.  The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R), a putative breast tumor suppressor gene , 1998, Breast Cancer Research and Treatment.

[224]  J. Church,et al.  Adrenal masses in patients with familial adenomatous polyposis , 1997, Diseases of the colon and rectum.

[225]  D. Leroith,et al.  Insulin-like Growth Factor-I Rapidly Activates Multiple Signal Transduction Pathways in Cultured Rat Cardiac Myocytes* , 1997, The Journal of Biological Chemistry.

[226]  R. Croyle,et al.  Psychologic aspects of cancer genetic testing , 1997, Cancer.

[227]  S. Mesiano,et al.  Developmental and functional biology of the primate fetal adrenal cortex. , 1997, Endocrine reviews.

[228]  J. Yokota,et al.  DNA damage-associated dysregulation of the cell cycle and apoptosis control in cells with germ-line p53 mutation. , 1997, Cancer research.

[229]  Y Wang,et al.  Positional cloning of the gene for multiple endocrine neoplasia-type 1. , 1997, Science.

[230]  C. Polychronakos,et al.  Aberrant imprinting of the insulin-like growth factor II receptor gene in Wilms' tumor , 1997, Oncogene.

[231]  A. Klippel,et al.  Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt , 1997, Molecular and cellular biology.

[232]  Wendy Chorley,et al.  Who should talk to patients with cancer about genetics? , 1997, BMJ.

[233]  W. Oelkers,et al.  Insulin-like growth factors enhance steroidogenic enzyme and corticotropin receptor messenger ribonucleic acid levels and corticotropin steroidogenic responsiveness in cultured human adrenocortical cells. , 1996, The Journal of clinical endocrinology and metabolism.

[234]  G. Chrousos,et al.  p53 mutations in adrenal tumors: Caucasian patients do not show the exon 4 "hot spot" found in Taiwan. , 1996, The Journal of clinical endocrinology and metabolism.

[235]  L. Donehower.  The p53-deficient mouse: a model for basic and applied cancer studies. , 1996, Seminars in cancer biology.

[236]  C. Larsson,et al.  Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy. , 1996, Cancer research.

[237]  C. Edwards,et al.  Clinical studies of multiple endocrine neoplasia type 1 (MEN1) , 1996, QJM : monthly journal of the Association of Physicians.

[238]  T. Ludwig,et al.  Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. , 1996, Developmental biology.

[239]  R. Bentley,et al.  M6P/IGF2 receptor: a candidate breast tumor suppressor gene. , 1996, Oncogene.

[240]  J. Fraumeni,et al.  Risk factors for adrenal cancer: An exploratory study , 1996, International journal of cancer.

[241]  R. Bellantone,et al.  The Italian Registry for Adrenal Cortical Carcinoma: analysis of a multiinstitutional series of 129 patients. The ACC Italian Registry Study Group. , 1996, Surgery.

[242]  J. Rastad,et al.  Adrenal lesion in multiple endocrine neoplasia type 1. , 1995, Surgery.

[243]  Z. Traill,et al.  Adrenal carcinoma in a patient with Gardner's syndrome: imaging findings. , 1995, AJR. American journal of roentgenology.

[244]  R. Camplejohn,et al.  A possible screening test for inherited p53-related defects based on the apoptotic response of peripheral blood lymphocytes to DNA damage. , 1995, British Journal of Cancer.

[245]  Ziying Liu,et al.  Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. , 1994, Genes & development.

[246]  E. Wagner,et al.  Regulation of embryonic growth and lysosomal targeting by the imprintedIgf2/Mpr gene , 1994, Nature.

[247]  C. Portwine,et al.  High frequency of germline p53 mutations in childhood adrenocortical cancer. , 1994, Journal of the National Cancer Institute.

[248]  E. Wolf,et al.  Consequences of postnatally elevated insulin-like growth factor-II in transgenic mice: endocrine changes and effects on body and organ growth. , 1994, Endocrinology.

[249]  G. Chrousos,et al.  Clonal composition of human adrenocortical neoplasms. , 1994, Cancer research.

[250]  I. Temple,et al.  Clinical features and natural history of Beckwith‐Wiedemann syndrome: presentation of 74 new cases , 1994, Clinical genetics.

[251]  D. Carson,et al.  Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers , 1994, Nature.

[252]  X. Bertagna,et al.  Clonal analysis of human adrenocortical carcinomas and secreting adenomas , 1994, Clinical endocrinology.

[253]  A. Craft,et al.  Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. , 1994, Cancer research.

[254]  G. Chrousos,et al.  p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies. , 1994, The Journal of clinical endocrinology and metabolism.

[255]  S. R. Lin,et al.  Mutations of the p53 gene in human functional adrenal neoplasms. , 1994, The Journal of clinical endocrinology and metabolism.

[256]  C. Purdie,et al.  Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. , 1994, Oncogene.

[257]  R. Weinberg,et al.  Tumor spectrum analysis in p53-mutant mice , 1994, Current Biology.

[258]  M. Wooten,et al.  Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature , 1993, Cancer.

[259]  L. Donehower,et al.  Spontaneous and carcinogen–induced tumorigenesis in p53–deficient mice , 1993, Nature Genetics.

[260]  V. Ilvesmäki,et al.  Insulin-like growth factor binding proteins in the human adrenal gland , 1993, Molecular and Cellular Endocrinology.

[261]  Benjamin Tycko,et al.  Tumour-suppressor activity of H19 RNA , 1993, Nature.

[262]  V. Ilvesmäki,et al.  Insulin-like growth factors (IGFs) and their receptors in adrenal tumors: high IGF-II expression in functional adrenocortical carcinomas. , 1993, The Journal of clinical endocrinology and metabolism.

[263]  P. Kleihues,et al.  p53 Mutations in sporadic adrenocortical tumors , 1993, International journal of cancer.

[264]  S. Friend,et al.  Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals. , 1992, Journal of the National Cancer Institute.

[265]  K. Kovacs,et al.  Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type 1 (MEN1): loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN1 locus. , 1992, The Journal of clinical endocrinology and metabolism.

[266]  J. Rastad,et al.  Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. , 1992, The Journal of clinical endocrinology and metabolism.

[267]  M. Seki,et al.  Loss of normal allele of the APC gene in an adrenocortical carcinoma from a patient with familial adenomatous polyposis , 1992, Human Genetics.

[268]  L. Donehower,et al.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.

[269]  M. Binoux,et al.  Effects of insulin-like growth factor I (IGF-I) on enzymatic activity in human adrenocortical cells. Interactions with ACTH , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[270]  S. Altschul,et al.  Identification of FAP locus genes from chromosome 5q21. , 1991, Science.

[271]  Margaret Robertson,et al.  Identification and characterization of the familial adenomatous polyposis coli gene , 1991, Cell.

[272]  V. Reuter,et al.  Oncocytic adrenal cortical adenoma. , 1991, Ultrastructural pathology.

[273]  T. Wagner,et al.  Elevated corticosterone levels in transgenic mice expressing human or bovine growth hormone genes. , 1991, Neuroendocrinology.

[274]  A. Efstratiadis,et al.  Parental imprinting of the mouse insulin-like growth factor II gene , 1991, Cell.

[275]  L. Strong,et al.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.

[276]  L. Medeiros,et al.  Cellular DNA Profiles of Benign and Malignant Adrenocortical Tumors , 1990, The American journal of surgical pathology.

[277]  V. Fazio,et al.  Mortality in patients with familial adenomatous polyposis , 1990, Diseases of the colon and rectum.

[278]  L Hagenäs,et al.  Steroid profile in urine: a useful tool in the diagnosis and follow up of adrenocortical carcinoma. , 1990, Acta endocrinologica.

[279]  P Blondeau,et al.  Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. , 1990, The New England journal of medicine.

[280]  M. Dahmer,et al.  Characterization of Insulin‐Like Growth Factor‐I Receptors in PC 12 Pheochromocytoma Cells and Bovine Adrenal Medulla , 1989, Journal of neurochemistry.

[281]  L. Medeiros,et al.  Pathologic Features of Prognostic Significance in Adrenocortical Carcinoma , 1989, The American journal of surgical pathology.

[282]  W. Blattner,et al.  A cancer family syndrome in twenty-four kindreds. , 1988, Cancer research.

[283]  S. Gammeltoft,et al.  Insulin-like growth factors are mitogens for rat pheochromocytoma PC 12 cells. , 1988, Biochemical and biophysical research communications.

[284]  M. Dahmer,et al.  Insulin and insulin-like growth factors stimulate deoxyribonucleic acid synthesis in PC12 pheochromocytoma cells. , 1988, Endocrinology.

[285]  E. Fishman,et al.  Primary adrenocortical carcinoma: CT evaluation with clinical correlation. , 1987, AJR. American journal of roentgenology.

[286]  R. Voutilainen,et al.  Coordinate tropic hormone regulation of mRNAs for insulin-like growth factor II and the cholesterol side-chain-cleavage enzyme, P450scc [corrected], in human steroidogenic tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[287]  P. Schofield,et al.  Expression of growth regulatory genes in primary human testicular neoplasms. , 1987, International journal of andrology.

[288]  J. Irminger,et al.  Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms tumors: expression at the mRNA and protein level. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[289]  Linda S. Bowlby,et al.  Flow cytometric analysis of adrenal cortical tumor DNA: Relationship between cellular DNA and histopathologic classification , 1986, Cancer.

[290]  D. Page,et al.  Comparison of adrenal cortical tumors in children and adults , 1986, Cancer.

[291]  J. Mulvihill,et al.  Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. , 1986, The New England journal of medicine.

[292]  F. Klein,et al.  Flow cytometric determinations of ploidy and proliferation patterns of adrenal neoplasms: an adjunct to histological classification. , 1985, The Journal of urology.

[293]  D. Jagelman,et al.  Adrenal adenomas and adrenal carcinomas in association with hereditary adenomatosis of the colon and rectum , 1985, Cancer.

[294]  H. Slooten,et al.  Morphologic characteristics of benign and malignant adrenocortical tumors , 1985, Cancer.

[295]  L. Weiss.  Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors , 1984, The American journal of surgical pathology.

[296]  H. Wiedemann.  Tumours and hemihypertrophy associated with Wiedemann-Beckwith syndrome , 1983, European Journal of Pediatrics.

[297]  M. Rastin,et al.  Adrenocortical Carcinoma with Tumour-Induced Hypoglycaemia 1 , 1983, Journal of the Royal Society of Medicine.

[298]  A. Bauman,et al.  Virilizing adrenocortical carcinoma. Development in a patient with salt-losing congenital adrenal hyperplasia. , 1982, JAMA.

[299]  D. Page,et al.  Prognostic factors in adrenal cortical tumors. A mathematical analysis of clinical and morphologic data. , 1979, American journal of clinical pathology.

[300]  Nan Faion T. Wu,et al.  The Beckwith-Wiedemann Syndrome , 1974, Clinical pediatrics.

[301]  J. Fraumeni,et al.  Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? , 1969, Annals of internal medicine.

[302]  F. Martin,et al.  Gardner's syndrome with adrenal carcinoma. , 1967, Australasian annals of medicine.

[303]  A. Auvinen,et al.  Malignant Tumors of the Central Nervous System , 2020, Occupational Cancers.

[304]  C. Hawes,et al.  Cytomegaly of the adrenal gland. , 1955, A.M.A. American journal of diseases of children.

[305]  P. Wermer.  Genetic aspects of adenomatosis of endocrine glands. , 1954, The American journal of medicine.

[306]  E. Gardner,et al.  Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. , 1953, American journal of human genetics.

[307]  E. Gardner.  A genetic and clinical study of intestinal polyposis, a predisposing factor for carcinoma of the colon and rectum. , 1951, American journal of human genetics.

[308]  H. B. Anderson.  A TUMOR OF THE ADRENAL GLAND WITH FATAL HYPOGLYCEMIA , 1930 .

[309]  J. Bertherat,et al.  Identification of a CpG island methylator phenotype in adrenocortical carcinomas. , 2013, The Journal of clinical endocrinology and metabolism.

[310]  S. Gruber,et al.  Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma. , 2013, The Journal of clinical endocrinology and metabolism.

[311]  R. Boldrini,et al.  Pediatric adrenocortical tumors: morphological diagnostic criteria and immunohistochemical expression of matrix metalloproteinase type 2 and human leucocyte-associated antigen (HLA) class II antigens. Results from the Italian Pediatric Rare Tumor (TREP) Study project. , 2012, Human pathology.

[312]  D. Schteingart.  High frequency of adrenal myelolipomas and testicular adrenal rest tumours in adult Norwegian patients with classical congenital adrenal hyperplasia because of 21-hydroxylase deficiency , 2012 .

[313]  M. Meng,et al.  Risk of catecholamine crisis in patients undergoing resection of unsuspected pheochromocytoma. , 2011, International braz j urol : official journal of the Brazilian Society of Urology.

[314]  G. Hannon,et al.  Small RNA sorting: matchmaking for Argonautes , 2011, Nature Reviews Genetics.

[315]  D. Schteingart.  Transcriptome Analysis Reveals that p53 and β-Catenin Alterations Occur in a Group of Aggressive Adrenocortical Cancers , 2011 .

[316]  A. Lacroix,et al.  Combined expression of BUB 1 B , DLGAP 5 , and PINK 1 as predictors of poor outcome in adrenocortical tumors : validation in a Brazilian cohort of adult and pediatric patients , 2011 .

[317]  J. Stockman.  F18-Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography Screening in Li-Fraumeni Syndrome , 2009 .

[318]  D. Schteingart.  Adrenocortical Carcinoma in the United States: Treatment Utilization and Prognostic Factors , 2009 .

[319]  R. Kuick,et al.  Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma. , 2009, The Journal of clinical endocrinology and metabolism.

[320]  M. Fassnacht,et al.  Epidemiology of Adrenocortical Carcinoma , 2009 .

[321]  T. Else.  Overview of genetic syndromes associated with adrenocortical cancer , 2009 .

[322]  D. Schteingart.  Detection of somatic β-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD) , 2009 .

[323]  J. Berg,et al.  Clinical cancer genetics , 2008 .

[324]  E. Baudin,et al.  Prognostic parameters of metastatic adrenocortical carcinoma. , 2007, The Journal of clinical endocrinology and metabolism.

[325]  G. Klöppel,et al.  Immunocytochemistry in adrenocortical tumours: A clinicomorphological study of 72 neoplasms , 2005, Virchows Archiv A.

[326]  A. Multani,et al.  Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice , 2004, Nature Genetics.

[327]  D. Le Roith.  The insulin-like growth factor system. , 2003, Experimental diabesity research.

[328]  W. Mcdougal.  An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. , 2002, The Journal of urology.

[329]  V. Pankratz,et al.  Pathologic features and expression of insulin-like growth factor-2 in adrenocortical neoplasms , 2001, Endocrine pathology.

[330]  K. Köhrer,et al.  Complete sequencing and messenger ribonucleic acid expression analysis of the MEN I gene in adrenal cancer. , 2000, The Journal of clinical endocrinology and metabolism.

[331]  M. Ozturk.  Genetic Aspects of Hepatocellular Carcinogenesis , 1999, Seminars in liver disease.

[332]  P. Heikkilä,et al.  Expression of inhibin alpha in the human adrenal gland and adrenocortical tumors. , 1998, Endocrine research.

[333]  C. Gicquel,et al.  Molecular markers for malignancy in adrenocortical tumors. , 1997, Hormone research.

[334]  R. Eeles.  Germline mutations in the TP53 gene. , 1995, Cancer surveys.

[335]  H. Sasano,et al.  Cell proliferation and apoptosis in normal and pathologic human adrenal. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[336]  D. Leroith,et al.  Insulin-like Growth Factors and Cancer , 1995, Annals of Internal Medicine.

[337]  N. Ling,et al.  Insulin-like growth factor-binding protein-2: the effect of human chorionic gonadotropin on its gene regulation and protein secretion and its biological effects in rat Leydig cells. , 1994, Molecular endocrinology.

[338]  R. Baxter,et al.  Binding proteins for the insulin-like growth factors: structure, regulation and function. , 1989, Progress in growth factor research.

[339]  J. Richie,et al.  Differentiation of malignant from benign adrenal masses: predictive indices on computed tomography. , 1985, AJR. American journal of roentgenology.

[340]  M. Zdraveva,et al.  [Neurofibromatosis in childhood]. , 1977, Godisen zbornik na Medicinskiot fakultet vo Skopje.

[341]  J. Fraumeni,et al.  Adrenocortical neoplasms with hemihypertrophy, brain tumors, and other disorders. , 1967, The Journal of pediatrics.

[342]  M. V. Volkov,et al.  [Adrenocortical tumors in children]. , 1952, Pediatriia.